New “Self-Amplifying” mRNA Coronavirus Vaccine Intended to Fight Alleged New Variants Enters Trial Phase

Shockingly, the next thing that Hoax Watch predicted is happening – and it is completely a coincidence.

The fact that we predicted this exact thing would happen is totally unrelated to the fact that it is now happening.

It’s very simple:

  • Hoax Watch predicted it because they are stupid right-wing conspiracy theorists.
  • The reason it is happening is because the government follows the science.

The science has found that we need new gene therapy “vaccines” because of the new variants.

The Guardian:

The first trials have begun of a Covid booster jab that it is hoped will offer good protection against a wide range of variants, researchers have revealed.

Covid jabs currently used in the UK trigger an immune response towards the coronavirus spike protein, which helps the virus get into human cells.

However, different variants of the coronavirus have different mutations in this protein, meaning a vaccine that works well against one variant may not be as effective against another.

The team behind the new booster jab hope to get around this problem by triggering an immune response towards the spike and non-spike proteins of the coronavirus.

This vaccine targets not just the spike protein but also the nucleocapsid protein. This varies much less than the spike protein and therefore the hope is that it will be more proof against current and future variants,” said Prof Andrew Ustianowski, a consultant in infectious diseases and tropical medicine at North Manchester General hospital, and chief investigator for the study.

The phase 1 trial is a collaboration between the US pharmaceutical company Gritstone, the University of Manchester and Manchester University NHS foundation trust and is expected to involve 20 participants aged 60 and over, all of whom have previously been vaccinated with the Oxford/AstraZeneca jab. Each participant will receive the booster, with one of two different doses.

Ustianowski told the Guardian the third and fourth participants were receiving their doses on Tuesday, with the expectation that all 20 would be dosed in the next two to three weeks. On Monday, Andrew and Helen Clarke from Bolton were the first to receive the vaccine.

Ustianowski said the trial would be looking at the safety and tolerability of the jab, as well as the boosting of existing immune responses towards the spike protein and the development of responses to the viral nucleocapsid, with results of interest expected in the next few months.

Lawrence Young, a virologist and professor of molecular oncology at the University of Warwick, who is not involved in the trial, said the new vaccine, known as a self-amplifying mRNA second-generation Sars-CoV-2 vaccine, or SAM, was really exciting.

Surely, this will be the last new vaccine booster for this deadly virus.

Or maybe, we will just have infinity boosters forever.

We just have to follow the science in order to figure out what the science says we should do next.